Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
LidoPain is a branded topical patch formulation containing lidocaine, an amide-type local anesthetic. Lidocaine works by blocking voltage-gated sodium channels in neuronal cell membranes, thereby inhibiting the initiation and conduction of nerve impulses. This results in localized numbness and pain relief at the site of application. The primary indication for lidocaine patches such as LidoPain is the management of pain associated with postherpetic neuralgia (nerve pain following shingles), but it may also be used off-label for other localized neuropathic or musculoskeletal pains. Lidocaine has a rapid onset and intermediate duration of action when applied topically, providing temporary relief from pain without causing loss of consciousness or systemic anesthesia[3][4][5][7].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on LidoPain.